Differential Effect of Liver Cirrhosis on the Pregnane X Receptor–Mediated Induction of CYP3A1 and 3A2 in the Rat
- 1 October 2014
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 42 (10) , 1617-1626
Abstract
Conflicting results have been obtained by clinical studies investigating the effect of liver cirrhosis on enzyme induction. Because ethical concerns do not give consent for methodologically rigorous studies in humans, we addressed this question by examining the effect of the prototypical inducer dexamethasone (DEX) on the pregnane X receptor (PXR)–mediated induction of CYP3A1 and 3A2 in a validated animal model of liver cirrhosis obtained by exposure of rats to carbon tetrachloride. For this purpose, we assessed mRNA levels, protein expressions, and enzymatic activities of both CYP3A enzymes, as well as mRNA and protein expressions of PXR in rat populations rigorously stratified according to the severity of liver insufficiency. Constitutive mRNA and protein expressions of CYP3A1 and CYP3A2 and their basal enzyme activities were not affected by liver dysfunction. DEX treatment markedly increased steady-state mRNA level, protein content, and enzymatic activity of CYP3A1 in healthy and cirrhotic rats, irrespective of the degree of liver dysfunction. On the contrary, the inducing effect of DEX on gene and protein expressions and enzyme activity of CYP3A2 was preserved in moderate liver insufficiency, whereas it was greatly curtailed when liver insufficiency became severe. mRNA and protein expressions of PXR were neither reduced by liver dysfunction nor increased by DEX treatment. These results indicate that even the inducibility of cytochrome P450 isoforms under the transcriptional control of the same nuclear receptor may be differentially affected by cirrhosis and may partly explain why conflicting results were obtained by human studies.Keywords
This publication has 49 references indexed in Scilit:
- Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target GenesPLOS ONE, 2013
- Differential Inducing Effect of Benzo[a]pyrene on Gene Expression and Enzyme Activity of Cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar RatsDrug Metabolism and Pharmacokinetics, 2012
- Effects of Hepatic Drug-metabolizing Enzyme Induction on Clinical Pathology Parameters in Animals and ManToxicologic Pathology, 2010
- Cytochrome P450 probe substrate metabolism kinetics in Sprague Dawley ratsXenobiotica, 2007
- Characterization of the Rhesus Monkey CYP3A64 Enzyme: Species Comparisons of CYP3A Substrate Specificity and Kinetics Using Baculovirus-Expressed Recombinant EnzymesDrug Metabolism and Disposition, 2006
- Predicting Inhibitory Drug—Drug Interactions and Evaluating Drug Interaction Reports Using Inhibition ConstantsAnnals of Pharmacotherapy, 2005
- Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesBritish Journal of Clinical Pharmacology, 1998
- Differential regulation of cytochrome P450 3A1 and P450 3A2 in rat liver following dexamethasone treatmentJournal of Biochemical Toxicology, 1995
- Regulation of Two Members of the Steroid-Inducible Cytochrome P450 Subfamily (3A) in RatsArchives of Biochemistry and Biophysics, 1993
- MICROSOMAL PROTEIN SYNTHESIS AND INDUCTION OF CYTOCHROME P‐450 IN CIRRHOTIC RAT LIVERImmunology & Cell Biology, 1984